You are here

  • Home
  • Archive
  • Volume 68, Issue Suppl 3
  • P236 Superior lung function with once-daily QVA149 translates into improvements in patient-reported breathlessness compared with placebo and tiotropium in COPD patients: the BLAZE study

Citation Tools

Article menu

Download PDFPDF

Inhaled therapy in COPD
P236 Superior lung function with once-daily QVA149 translates into improvements in patient-reported breathlessness compared with placebo and tiotropium in COPD patients: the BLAZE study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
D'Urzo A, Mahler D, Decramer M, et al
P236 Superior lung function with once-daily QVA149 translates into improvements in patient-reported breathlessness compared with placebo and tiotropium in COPD patients: the BLAZE study
Thorax 2013;68:A184.